for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Hologic, Inc.

HOLX.OQ

Latest Trade

67.01USD

Change

0.11(+0.16%)

Volume

713,439

Today's Range

66.57

 - 

67.79

52 Week Range

26.49

 - 

73.63

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
66.90
Open
66.81
Volume
713,439
3M AVG Volume
46.61
Today's High
67.79
Today's Low
66.57
52 Week High
73.63
52 Week Low
26.49
Shares Out (MIL)
258.99
Market Cap (MIL)
17,326.11
Forward P/E
21.57
Dividend (Yield %)
--

Next Event

Q4 2020 Hologic Inc Earnings Release

Latest Developments

More

Hologic Announces Pricing Of Offering Of $950 Mln Of 3.25% Senior Notes

Hologic Reports Offering Of $950 Mln Of Senior Notes Due 2029

Hologic to Acquire Acessa Health For Approxi $80 Million

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Hologic, Inc.

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.

Industry

Medical Equipment & Supplies

Contact Info

250 Campus Dr

MARLBOROUGH, MA

01752-3020

United States

+1.508.2632900

https://www.hologic.com/

Executive Leadership

Stephen P. MacMillan

Chairman of the Board, President, Chief Executive Officer

Karleen Marie Oberton

Chief Financial Officer

Kevin R. Thornal

Division President, Diagnostics

Peter J. Valenti

Division President - Breast and Skeletal Health

Allison P. Bebo

Senior Vice President - Human Resources

Key Stats

1.75 mean rating - 16 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

3.1K

2018

3.2K

2019

3.4K

2020(E)

3.5K
EPS (USD)

2017

2.030

2018

2.230

2019

2.430

2020(E)

3.101
Price To Earnings (TTM)
35.88
Price To Sales (TTM)
5.26
Price To Book (MRQ)
7.68
Price To Cash Flow (TTM)
19.50
Total Debt To Equity (MRQ)
147.07
LT Debt To Equity (MRQ)
121.91
Return on Investment (TTM)
9.00
Return on Equity (TTM)
7.41

Latest News

Latest News

BRIEF-Hologic Launches Its First Cart-Based Ultrasound System, Supersonic Mach 40

* HOLOGIC LAUNCHES ITS FIRST CART-BASED ULTRASOUND SYSTEM, SUPERSONIC™ MACH 40 Source text for Eikon: Further company coverage:

BRIEF-Grifols Collaborates With Hologic To Increase Spain's COVID-19 Testing Capacity

* ANNOUNCES COLLABORATION WITH HOLOGIC INC TO INCREASE THE COUNTRY’S TESTING CAPACITY FOR COVID-19

BRIEF-Hologic Sees Q3 Diagnostics Revenue To Grow 20-25%

* HOLOGIC INC SEES Q3 BREAST AND SKELETAL HEALTH REVENUE TO DECLINE 30-35%.

Hologic's latest COVID-19 test gets FDA approval for emergency use

Hologic Inc said on Friday the U.S. Food and Drug Administration granted emergency use authorization for its COVID-19 diagnostic test that can provide initial results in about three hours and process more than 1,000 tests in 24 hours.

BRIEF-Hologic Granted FDA Emergency Use Authorization For Its Second Molecular Test For Covid-19

* HOLOGIC GRANTED FDA EMERGENCY USE AUTHORIZATION FOR ITS SECOND MOLECULAR TEST FOR COVID-19

BRIEF-Hologic To Introduce Second High-Throughput Molecular Assay For Novel Coronavirus

* HOLOGIC TO INTRODUCE ITS SECOND HIGH-THROUGHPUT MOLECULAR ASSAY FOR THE NOVEL CORONAVIRUS (SARS-COV-2)

Hologic launches second COVID-19 test to help reach more Americans

Hologic Inc on Wednesday said it is launching a second COVID-19 test that will help to dramatically expand testing capabilities in the United States.

BRIEF-Hologic Reports Financial Results For Q2 2020

* HOLOGIC ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL 2020

BRIEF-Hologic Withdraws 2020 Financial Guidance Due To Covid-19 Pandemic

* HOLOGIC ANNOUNCES PRELIMINARY REVENUE RESULTS FOR SECOND QUARTER OF FISCAL 2020, WITHDRAWS 2020 FINANCIAL GUIDANCE DUE TO COVID-19 PANDEMIC

BRIEF-Hologic - U.S. FDA-Issuing Emergency Use Authorizations To Hologic For Its Panther Fusion Sars-Cov-2 Assay

* U.S. FDA-ISSUING EMERGENCY USE AUTHORIZATIONS TO HOLOGIC FOR ITS PANTHER FUSION SARS-COV-2 ASSAY

BRIEF-Hologic's Molecular Test For The Novel Coronavirus, Sars-Cov-2, Receives FDA Emergency Use Authorization

* HOLOGIC’S MOLECULAR TEST FOR THE NOVEL CORONAVIRUS, SARS-COV-2, RECEIVES FDA EMERGENCY USE AUTHORIZATION

Hologic gets U.S. funding for coronavirus test kit

The U.S. Department of Health and Human Services said on Monday it will provide financial aid to Hologic Inc to develop a coronavirus diagnostic kit that would be able to process up to 1,000 tests in 24 hours.

BRIEF-HHS Supports Development Of First High-Throughput Covid-19 Diagnostic Test

* HHS Supports Development Of First High-Throughput Covid-19 Diagnostic Test

Hologic gets U.S. funding for coronavirus test kit

The U.S. Department of Health and Human Services said on Monday it would contribute $699,000 to speed up Hologic Inc's development of a coronavirus diagnostic test.

Hologic gets defense verdict in $90 million DNA testing patent case

Hologic Inc, its partner Grifols SA, and their lawyers at Arnold & Porter Kaye Scholer on Tuesday secured a defense verdict in a patent infringement case brought by rival medical diagnostics company bioMérieux SA.

Hologic loses bid to dismiss bioMerieux's HIV test patent case

Diagnostic testing company bioMerieux SA can move forward with a lawsuit alleging that HIV testing kits manufactured by rival Hologic Inc infringe two of its patents, a federal judge in Delaware has ruled.

Hologic wins $4.8 million from Minerva Surgical in patent trial

A federal jury on Friday awarded medical device maker Hologic Inc $4.8 million in its patent infringement lawsuit against rival Minerva Surgical Inc.

BRIEF-Hologic Receives Health Canada Authorization To Market Sculpsure Laser

* HOLOGIC RECEIVES HEALTH CANADA AUTHORIZATION TO MARKET SCULPSURE® LASER FOR NON-INVASIVE BODY CONTOURING (LIPOLYSIS) OF THE BACK, INNER AND OUTER THIGHS, AND UNDER THE CHIN Source text for Eikon: Further company coverage:

BRIEF-Hologic Q2 GAAP Loss Per Share $2.46

* HOLOGIC ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL 2018

BRIEF-FDA Approval Of Thinprep Integrated Imager Expands Automated Imaging For Pap Testing To More Labs

* FDA APPROVAL OF THINPREP® INTEGRATED IMAGER EXPANDS AUTOMATED IMAGING FOR PAP TESTING TO MORE LABS

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up